Hooftman Leoninsider trades
In SEC Form 4 filings, Hooftman Leon is listed as Chief Medical Officer of Barinthus Biotherapeutics plc. (BRNS). Hooftman Leon reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 9.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BRNSBarinthus Biotherapeutics plc. | Chief Medical Officer | 4 | Sep 9 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-09
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | A | 361,530 | not reported | not reported | 361,530 | No | Form 4 |
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D | 361,530 | not reported | not reported | not reported | No | Form 4 |
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D · derivative | 195,166 | $2.00 | $390,332 | not reported | No | Form 4 |
| BRNSBarinthus Biotherapeutics plc. | Sep 9 | Sep 9 | D · derivative | 140,000 | $1.00 | $140,000 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.